These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32396390)

  • 1. Cryptic Splice-Altering Variants in
    Lopes LR; Barbosa P; Torrado M; Quinn E; Merino A; Ochoa JP; Jager J; Futema M; Carmo-Fonseca M; Monserrat L; Syrris P; Elliott PM
    Circ Genom Precis Med; 2020 Jun; 13(3):e002905. PubMed ID: 32396390
    [No Abstract]   [Full Text] [Related]  

  • 2. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
    Singer ES; Ingles J; Semsarian C; Bagnall RD
    Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in
    Holliday M; Singer ES; Ross SB; Lim S; Lal S; Ingles J; Semsarian C; Bagnall RD
    Circ Genom Precis Med; 2021 Apr; 14(2):e003202. PubMed ID: 33657327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies.
    Frisso G; Detta N; Coppola P; Mazzaccara C; Pricolo MR; D'Onofrio A; Limongelli G; Calabrò R; Salvatore F
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy.
    Xin B; Puffenberger E; Tumbush J; Bockoven JR; Wang H
    Am J Med Genet A; 2007 Nov; 143A(22):2662-7. PubMed ID: 17937428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pathogenic gene mutations in
    Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
    Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
    J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain).
    Reguero JR; Gómez J; Martín M; Flórez JP; Morís C; Iglesias S; Alonso B; Alvarez V; Coto E
    Int J Cardiol; 2013 Oct; 168(4):4555-6. PubMed ID: 23870641
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional characterization of putative novel splicing mutations in the cardiomyopathy-causing genes.
    Millat G; Lafont E; Nony S; Rouvet I; Bozon D
    DNA Cell Biol; 2015 Jul; 34(7):489-96. PubMed ID: 25849606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene symbol: MYBPC3. Disease: Hypertrophic cardiomyopathy.
    Golubenko MV; Puzyrev KV; Puzyrev VP; Pavlukova EN; Makeeva OA; Vosberg HP
    Hum Genet; 2004 Mar; 114(4):406. PubMed ID: 15046084
    [No Abstract]   [Full Text] [Related]  

  • 14. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
    Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
    Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel human pathological mutations. Gene symbol: MYBPC3. Disease: cardiomyopathy, hypertrophic.
    Rodriguez-Garcia MI; Monserrat L; Ortiz M; Fernández X; Cazón L; Núñez L; Barriales-Villa R; Maneiro E; Veira E; Castro-Beiras A; Hermida-Prieto M
    Hum Genet; 2010 Apr; 127(4):484. PubMed ID: 21488307
    [No Abstract]   [Full Text] [Related]  

  • 16. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.
    Erdmann J; Raible J; Maki-Abadi J; Hummel M; Hammann J; Wollnik B; Frantz E; Fleck E; Hetzer R; Regitz-Zagrosek V
    J Am Coll Cardiol; 2001 Aug; 38(2):322-30. PubMed ID: 11499719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Long-Read RNA Sequencing Demonstrates Transcriptional Diversity Driven by Splice-Site Variation in MYBPC3.
    Dainis A; Tseng E; Clark TA; Hon T; Wheeler M; Ashley E
    Circ Genom Precis Med; 2019 May; 12(5):e002464. PubMed ID: 31112421
    [No Abstract]   [Full Text] [Related]  

  • 18. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
    Adalsteinsdottir B; Teekakirikul P; Maron BJ; Burke MA; Gudbjartsson DF; Holm H; Stefansson K; DePalma SR; Mazaika E; McDonough B; Danielsen R; Seidman JG; Seidman CE; Gunnarsson GT
    Circulation; 2014 Sep; 130(14):1158-67. PubMed ID: 25078086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human myosin-binding protein C3 variants associated with hypertrophic cardiomyopathy reveals exon-specific cardiac phenotypes in zebrafish model.
    Da'as SI; Yalcin HC; Nasrallah GK; Mohamed IA; Nomikos M; Yacoub MH; Fakhro KA
    J Cell Physiol; 2020 Nov; 235(11):7870-7888. PubMed ID: 31943169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.